Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Why Aurora Cannabis Fell 18.9% in October

By Billy Duberstein - Nov 3, 2019 at 10:19PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The leading Canadian cannabis producer fell in sympathy with the rest of the industry.

What happened

Canadian cannabis production leader Aurora Cannabis ( ACB -6.39% ) fell 18.9% in October, according to data from S&P Global Market Intelligence. But the bad news doesn't stop there. In fact, Aurora's October decline followed an even greater 20.7% sell-off in September, which itself came after a 10.9% decline in August.

There wasn't too much company-specific news in the month, as Aurora continued to fall with the rest of the large publicly traded cannabis stocks, which have suffered from industrywide bad news.

Three rolled joints lying among cannabis buds.

Image source: Getty Images.

So what

October was supposed to be an exciting month for cannabis companies, as Canada's Cannabis 2.0 took effect on Oct. 17. That was the date when companies received the green light to sell higher-margin derivative products such as edibles and vapes.

However, cannabis stocks have been under fire ever since summer. The problem started with the release of Canada Health data showing that cannabis companies were sitting on huge amounts of inventory that they had been unable to sell. This has been due to both a delay in Canadian infrastructure rollout, as well as competition from the black market.

Earnings reports from several Canadian companies then underwhelmed, including Aurora's September earnings release. That seemed to validate the data that these cannabis producers had vastly oversupplied legal demand in Canada -- and by a large amount.

Then on Oct. 10, fellow Canadian peer HEXO reported horrible earnings and pulled its 2020 full-year guidance, again confirming the oversupply fears and sending the rest of the industry further into a tailspin.

Now what

Aurora is in a tough spot, with Canadian infrastructure delays putting pricing pressure on all legal cannabis companies. Even Cannabis 2.0 may not be a saving grace: Though the new rules kicked in this month, derivative products could take another two months to even hit store shelves. It's also hard to determine if demand for these new products could make a dent in the enormous inventories throughout the Canadian system. 

Complicating things further, these companies are all losing money, so time is of the essence. Aurora itself has a large 230 million Canadian dollar convertible note due in March 2020. Though the company has options to deal with the looming debt maturity, these could include adding more debt or issuing new equity at low prices.

Aurora is still a best-in-class operator in the cannabis space, but until the Canadian infrastructure problem and associated oversupply disaster are solved, expect more pressure on Aurora and the rest of this fledgling industry.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
ACB
$6.01 (-6.39%) $0.41

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
635%
 
S&P 500 Returns
141%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/02/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.